Centralization and Oncologic Outcomes in Ovarian Cancer

Recruiting now

Conditions studied: Epithelial Ovarian Cancer, Ovarian Neoplasms, Advanced Ovarian Cancer

In brief

This is a multicenter, observational, retrospective and prospective study conducted within the REMO (Reggio Emilia - Modena) network in the Emilia-Romagna region (Italy), promoted by AUSL-IRCCS of Reggio Emilia. The study aims to evaluate the impact of surgical centralization and treatment strategies adopted during the COVID-19 pandemic on oncologic outcomes in patients diagnosed with the epithelial ovarian cancer (EOC) from 2018 to 2023. The retrospective component includes patients treated between 2018 and 2023, while the prospective component consists of clinical follow-up of those patients over the next five years.

Key facts

Study ID
NCT07075939
Run by
Azienda USL Reggio Emilia - IRCCS
People needed
200
Starts
2025-06-27
Expected to finish
2031-06-01
Last updated by the study team
2026-07-24

Who can join

Age: 18 and older, up to 99. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.